CIK 0001610820 · Non-accelerated filer<br>Smaller reporting company
BriaCell Therapeutics Corp.
Sign in to watch- Ticker
- BCTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jul 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 921-1810
- Business address
- 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, V7T 2X1
- Former names
- Ansell Capital Corp.
Securities
- BCTX Common Shares Nasdaq
- BCTXL Warrants Nasdaq
- BCTXZ Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-14 | Lustig Marc Director | Purchase | +902,935 | $2.22 | $2.0M | 2,542,935 |
| 2024-05-14 | Lustig Marc Director | Purchase · Common Stock Warrants | +902,935 | 902,935 | ||
| 2022-12-28 | Bondarenko Jamieson Chairman | Purchase | +28,000 | $4.58 | $128K | 169,856 |
| 2022-12-23 | Williams William V. President, CEO | Purchase · Warrant | +2,530 | $1.94 | $5K | 29,802 |
| 2022-12-20 | Bondarenko Jamieson Director | Purchase | +22,000 | $5.35 | $118K | 141,856 |
Page 1 of 1 · 5 trades